Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19

Original Article

M.J. Levin, A. Ustianowski, S.D. Wit, O. Launay, M. Avila, A. Templeton, Y. Yuan, S. Seegobin, A. Ellery, D.J. Levinson, P. Ambery, R.H. Arends, R. Beavon, K. Dey, P. Garbes, E.J. Kelly, G.C. Koh, K.A. Near, K.W. Padilla, K. Psachoulia, A. Sharbaugh, K. Streicher, M.N. Pangalos, and M.T. Esser

N Engl J Med 2022;386:2188-2200

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
06/08/2022
Course expires: 
06/09/2024

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, June 9, 2024 - 11:59pm.